Drug Shortage Report for DEPAKENE
| Report ID | 7165 |
| Drug Identification Number | 00443840 |
| Brand name | DEPAKENE |
| Common or Proper name | Depakene |
| Company Name | BGP PHARMA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | VALPROIC ACID |
| Strength(s) | 250MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N03AG |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2017-01-25 |
| Estimated end date | |
| Actual end date | 2017-04-24 |
| Shortage status | Resolved |
| Updated date | 2017-06-08 |
| Company comments | This product has been discontinued. A discontinuation report has been created as the product was discontinued on 2017-04-24. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2017-06-08 | French | Compare |
| v5 | 2017-06-08 | English | Compare |
| v4 | 2017-05-10 | English | Compare |
| v3 | 2017-05-10 | English | Compare |
| v2 | 2017-04-18 | French | Compare |
| v1 | 2017-04-18 | English | Compare |
Showing 1 to 6 of 6